Bruker Expands Spatial Biology Portfolio with Multiomic Workflows at AACR 2026
Event summary
- Bruker Spatial Biology launches cross-platform workflows linking GeoMx DSP, CellScape XR, and CosMx SMI at AACR 2026.
- New 208-plex datasets from CellScape XR debut for subcellular proteomics in oncology applications.
- PaintScape platform now open for pre-orders with shipments expected this quarter.
- CellScape XR pre-orders accepted, with commercial shipments expected this summer.
- CosMx SMI extends capabilities to mouse whole transcriptome and TCR/miRNA imaging.
The big picture
Bruker's latest advancements at AACR 2026 underscore its strategic focus on integrating high-fidelity spatial biology platforms to deliver deeper insights into oncology. The company's ability to connect multiple omic layers positions it at the forefront of translational research, addressing the growing demand for comprehensive, multiomic solutions in cancer biology. The commercialization of PaintScape and CellScape XR platforms will be critical in expanding Bruker's market reach and solidifying its role in the post-genomic era.
What we're watching
- Integration Impact
- How Bruker's cross-platform workflows will affect the adoption of multiomic insights in translational research.
- Market Differentiation
- Whether Bruker can sustain its leadership in spatial biology with these high-fidelity platforms.
- Commercialization Pace
- The pace at which PaintScape and CellScape XR platforms will be adopted by research institutions.
Related topics